Savara Inc — Director's Dealing 2010

Feb 4, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADVENTRX PHARMACEUTICALS INC (ANX)
CIK: 0001160308
Period of Report: 2010-02-02

Reporting Person: Kostas Odysseas D (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-02-02	Non-qualified Stock Option (Right to Buy)	$0.32	A	100000	Acquired	2020-02-02	Common Stock (100000)	Direct
2010-02-02	Non-qualified Stock Option (Right to Buy)	$0.32	A	33332	Acquired	2020-02-02	Commmon Stock (33332)	Direct

Footnotes

F1: This option vests and becomes exercisable as to 1/36th of the shares subject to this option at the end of each successive month after February 2010.

F2: This option vests and becomes exercisable as to 1/4th of the shares subject to this option at the end of each succesive month after February 2010.